Home › Lung Diseases › Illinois
Lung Diseases clinical trials in Illinois
16 studies for Lung Diseases are looking for participants at sites in Illinois.
Cities in Illinois
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Northwestern Memorial Hospital, Chicago
- Northwestern University Feinberg School of Medicine, Chicago
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07013474Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- Hope and Healing Clinical Research, Hinsdale
- Hope and Healing Clinical Research, New Lenox
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07489066A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Axis Clinical Trials - Westchester, Westchester
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Sep 25, 2026 · NCT07759245A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Koch Family Medicine, Morton
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT06679140American Lung Association (ALA) Lung Health Cohort
- University of Illinois at Chicago, Chicago
- Northwestern University, Chicago
- Rush Universtiy, Chicago
RecruitingObservational studyHealthy volunteers welcome
Ages 25 to 35 · All sexes · Updated Sep 23, 2026 · NCT04543461A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Christie Clinic - University, Champaign
- Innovo Research - Christie Clinic, Champaign
- Christie Clinic - Windsor, Champaign
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 22, 2026 · NCT06977581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of Illinois at Chicago, Chicago
- University of Chicago Hospital, Chicago
- Springfield Clinic Main Campus, Springfield
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT07059091A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Chicago
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Sep 2, 2026 · NCT07333183Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Evanston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05624450Deep Functional Phenotyping of the ALA Lung Health Cohort
- Northwestern University, Chicago
RecruitingObservational studyHealthy volunteers welcome
Ages 25 to 35 · All sexes · Updated Jul 17, 2026 · NCT06177717Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- Advocate Aurora Health, Park Ridge
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jun 26, 2026 · NCT04614103A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- University of Chicago, Chicago
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Edward Hines Jr. VA Hospital, Hines, IL, Hines
Recruiting
Ages 18 and older · All sexes · Updated Feb 19, 2026 · NCT02984761A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- University of Illinois Medical Center - Hematology & Oncology, Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- University of Illinois Health, Chicago
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 12, 2024 · NCT02735707From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.